Amosartan wins Jang Young Sil Award
Published: 2010-09-08 06:56:00
Updated: 2010-09-08 06:56:00
Hanmi Pharm’s Amorsartan, a combination drug of amlodipine camsylate and losartan potassium, has won IR52 Jang Young Sil Award for its contribution in upgrading the country’s drug technologies and in expanding overseas market share, officials said on September 3.
The Korea Industrial Technolog...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
